EM · Electrolyte emergencies — potassium and sodium
Electrolyte emergencies — potassium and sodium
Also known as Hyperkalaemia · Hyponatraemia · Osmotic demyelination syndrome · Hypokalaemia · Hypernatraemia · Diabetes insipidus
Electrolyte emergencies — potassium and sodium. Hyperkalaemia (a serum potassium over 6.5 mmol/L, or any level with ECG change) is a time-critical arrhythmia risk treated up an antidote ladder of membrane stabilisation (calcium chloride 10 mL of 10 per cent IV), potassium shift (insulin 10 units with 50 mL of 50 per cent dextrose IV, salbutamol 10 to 20 mg nebulised, sodium bicarbonate IV reserved for metabolic acidosis) and potassium removal (patiromer, sodium zirconium, dialysis). Hypokalaemia (potassium under 3.5 mmol/L) shows U waves and a prolonged QU interval, precipitates torsades de pointes and potentiates digoxin toxicity, and is replaced intravenously at no faster than 10 mmol per hour peripherally and 20 mmol per hour centrally, with the magnesium corrected first. Hyponatraemia (sodium under 125 mmol/L) splits into acute — cerebral oedema and seizure, treated with 3 per cent hypertonic saline 100 mL IV bolus — and chronic, corrected slowly (under 8 mmol/L in 24 hours to avoid osmotic demyelination). Hypernatraemia (sodium over 145 mmol/L) is always a water-deficit problem, corrected at no faster than 0.5 mmol/L per hour with free water (oral or 5 per cent dextrose) and desmopressin for central diabetes insipidus. The ECG changes of hyperkalaemia (peaked T waves, widened QRS, sine wave, VF arrest), the pseudohyperkalaemia trap, and the corrected sodium for hyperglycaemia. ACEM-primary, globally tagged.
Checked against its sources on 1 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Any ECG change of hyperkalaemia is a cardiac arrest precursor — give calcium first, do not wait for the potassium result
- Peaked T waves progressing to a widened QRS or a sine wave heralds VF or asystole within minutes
- Acute hyponatraemia (under 48 hours, sodium under 125 mmol/L) with seizure or coma is cerebral oedema — give 3 per cent hypertonic saline 100 mL IV bolus now
- Correcting chronic hyponatraemia faster than 8 mmol/L in 24 hours risks osmotic demyelination — lock the rate to the symptoms
- A haemolysed sample reads falsely high — repeat the potassium before dialysis if the trace looks normal
Meet the patient
A 64-year-old dialysis non-attender is brought in seizing, his monitor showing a sine-wave bradycardia — the venous gas returns a potassium of 8.1 mmol/L within three minutes. Two beds away, a 38-year-old post-operative woman has had two tonic-clonic seizures and a sodium of 116 mmol/L.[2][3]
Two electrolytes, two brains, two clocks. The potassium must come down in minutes (calcium first, then insulin-dextrose). The sodium needs an initial rise of 4–6 mmol/L to reverse the encephalopathy — and no more than 8 mmol/L in 24 hours thereafter, or the adapted brain demyelinates. The candidate who treats both disturbances as the same emergency fails the station and harms the patient: the duration of onset, not the absolute number, sets the rate.[16]
References42ShowHide
- [1]Geldermann N, Dzimiera J, Fischer H, Christ M Acute hyperkalaemia in emergency care: evidence-based approaches Emerg Med J, 2026.PMID 41506858
- [2]Lemoine L, Le Bastard Q, Batard E, et al. An Evidence-Based Narrative Review of the Emergency Department Management of Acute Hyperkalemia J Emerg Med, 2021.PMID 33423833
- [3]Adrogué HJ, Tucker BM, Madias NE. Diagnosis and Management of Hyponatremia: A Review JAMA, 2022.PMID 35852524
- [4]Prince R, Chifu I, Arshad MF The treatment of acute symptomatic hyponatraemia in the hospital setting Best Pract Res Clin Endocrinol Metab, 2026.PMID 41402221
- [5]Adrogué HJ, Madias NE. Hypernatremia N Engl J Med, 2000.PMID 10816188
- [6]Unwin RJ, Luft FC, Shirley DG. Pathophysiology and management of hypokalemia: a clinical perspective Nat Rev Nephrol, 2011.PMID 21278718
- [7]Gennari FJ. Disorders of potassium homeostasis. Hypokalemia and hyperkalemia Crit Care Clin, 2002.PMID 12053834
- [8]Allon M, Dunlay R, Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis Ann Intern Med, 1989.PMID 2919849
- [9]Allon M, Copkney C. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients Kidney Int, 1990.PMID 2266671
- [10]Weir MR, Bakris GL, Bushinsky DA, et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors N Engl J Med, 2015.PMID 25415805
- [11]Long B, Warix JR, Koyfman A. Controversies in Management of Hyperkalemia J Emerg Med, 2018.PMID 29731287
- [12]Sterns RH, Hix JK, Silver S Treatment of hyponatremia Curr Opin Nephrol Hypertens, 2010.PMID 20539224
- [13]Singh TD, Fugate JE, Rabinstein AA. Central pontine and extrapontine myelinolysis: a systematic review Eur J Neurol, 2014.PMID 25220878
- [14]Ayus JC, Moritz ML Misconceptions and Barriers to the Use of Hypertonic Saline to Treat Hyponatremic Encephalopathy Front Med (Lausanne), 2019.PMID 30931308
- [15]Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia Eur J Endocrinol, 2014.PMID 24569125
- [16]Sterns RH, Silver SM. Complications and management of hyponatremia Curr Opin Nephrol Hypertens, 2016.PMID 26735146
- [17]Mahoney BA, Smith WAD, Lo DS, Tsoi K, Tonelli M, Clase CM. Emergency interventions for hyperkalaemia Cochrane Database Syst Rev, 2005.PMID 15846652
- [18]Kovesdy CP. Management of Hyperkalemia: An Update for the Internist Am J Med, 2015.PMID 26093176
- [19]Yun G, Baek SH, Kim S. Evaluation and management of hypernatremia in adults: clinical perspectives Korean J Intern Med, 2023.PMID 36578134
- [20]Liamis G, Filippatos TD, Elisaf MS. Evaluation and treatment of hypernatremia: a practical guide for physicians Postgrad Med, 2016.PMID 26813151
- [21]Harel Z, Kamel KS. Optimal dose and method of administration of intravenous insulin in the management of emergency hyperkalemia: a systematic review PLoS One, 2016.PMID 27148740
- [22]Jacob BC, Peasah SK, Chan HL. Hypoglycemia associated with insulin use during treatment of hyperkalemia among emergency department patients Hosp Pharm, 2019.PMID 31205332
- [23]Maeoka Y, Duan XP, Zhang CB. Hypomagnesaemia-associated hypokalaemia requires activation of both ENaC and ROMK J Physiol, 2025.PMID 41137719
- [24]Lim S. Approach to hypokalemia Acta Med Indones, 2007.PMID 17297212
- [25]Meng QH, Wagar EA. Pseudohyperkalemia: a new twist on an old phenomenon Crit Rev Clin Lab Sci, 2015.PMID 25319088
- [26]Hoorn EJ, Tuut MK, Hoorntje SJ. Dutch guideline for the management of electrolyte disorders — 2012 revision Neth J Med, 2013.PMID 23712815
- [27]Castro D, Sharma S. Hypokalemia StatPearls, 2025.PMID 29494072
- [28]Fraser CL, Arieff AI. Epidemiology, pathophysiology, and management of hyponatremic encephalopathy Am J Med, 1997.PMID 9209203
- [29]Moritz ML, Ayus JC. Management of hyponatremia in various clinical situations Curr Treat Options Neurol, 2014.PMID 25099180
- [30]Ambati R, Kho LK, Prentice D, et al. Osmotic demyelination syndrome: novel risk factors and proposed pathophysiology Intern Med J, 2023.PMID 35717664
- [31]Beckmann SB, Rudolphi CF, Silva PHI, et al. Thiazide-induced hyponatremia Best Pract Res Clin Endocrinol Metab, 2026.PMID 41130861
- [32]Armstrong LE, McDermott BP, Young SL, et al. Exercise-associated hyponatremia: serum sodium, symptomatology, severity, and sport specificity Open Access J Sports Med, 2025.PMID 41280657
- [33]Atila C, Straumann I, Vizeli P, et al. Oxytocin and the role of fluid restriction in MDMA-induced hyponatremia: a secondary analysis of 4 randomized clinical trials JAMA Netw Open, 2024.PMID 39546312
- [34]Vaz de Castro PAS, Bitencourt L, de Oliveira Campos JL, et al. Nephrogenic diabetes insipidus: a comprehensive overview J Pediatr Endocrinol Metab, 2022.PMID 35146976
- [35]Banai S, Tzivoni D. Drug therapy for torsade de pointes J Cardiovasc Electrophysiol, 1993.PMID 8269292
- [36]Mittal R, Lai AMW, Coskin R, et al. Comprehensive overview of hypernatremia: pathophysiology, diagnosis, and management Br J Hosp Med (Lond), 2025.PMID 41443222
- [37]Almarzuqi A, Kimber S, Quadros K, et al. Bidirectional ventricular tachycardia: challenges and solutions Vasc Health Risk Manag, 2022.PMID 35698640
- [38]Lin XH, Hsu YC. Pseudohyperkalemia in a patient with leukemia: a diagnostic pitfall in emergency medicine J Emerg Med, 2025.PMID 40850066
- [39]Ravioli S, Edenhofner A, Schwarz C, et al. Comparison of sodium and potassium measurements in the emergency department by point-of-care vs. central laboratory testing: a retrospective analysis Wien Klin Wochenschr, 2026.PMID 41973115
- [40]Chan BS, Buckley NA. Digoxin-specific antibody fragments in the treatment of digoxin toxicity Clin Toxicol (Phila), 2014.PMID 25089630
- [41]Atila C, Consoli C, Christ-Crain M. Arginine vasopressin deficiency: towards a better characterization Endocr Relat Cancer, 2026.PMID 42677919
- [42]Tzivoni D, Keren A, Cohen AM, et al. Magnesium therapy for torsades de pointes. Am J Cardiol, 1984.PMID 6695782